Relationship between adenomyosis and uterine polyps.

U. Indraccolo,F. Barbieri

DOI: https://doi.org/10.1016/j.ejogrb.2011.02.014

2011-08-01

Abstract:

What problem does this paper attempt to address?

A Multiple Perspectives on Atypical Polypoid Adenomyoma of Uterus.

Qiao-Ying Jiang,Liang Wang,Rui-Jin Wu

DOI: https://doi.org/10.3109/09513590.2013.777418

2013-01-01

Gynecological Endocrinology

Abstract:Atypical polypoid adenomyoma (APA) is a rare benign uterine tumor, with less than 200 cases have been reported in English literature. Although, it is considered as a benign lesion and treated conservatively previously, more and more cases show that APA has a high rate of recurrence or residual, and is found to precede the development of carcinoma. Given the data from present research on APA, the therapy of APA becomes more complex and must be cautious, especially for the nulliparous and premenopausal patients. In addition, because of the low incidence, studies on this disease are less, and the etiology and pathogenesis of APA is still unclear. In this review, we aim to summarize recent researches concerning APA from multiple perspectives, including clinical presentation, histogenesis, immunohistochemistry and molecular features, diagnosis and differential diagnosis, treatment opinion and prognosis, which may provide theory and clinical basis for the future clinical treatment and research of this rare disease.
Clinicopathologic characteristics of uterine adenomyoma in pregnant women.

Jian-Hua Wang,Xiao-Hong He,Rui-Jin Wu,Xiang-Rong Xu

DOI: https://doi.org/10.1016/j.fertnstert.2006.11.083

IF: 6.7

2007-01-01

Fertility and Sterility

Abstract:To study the clinicopathologic characteristics and the treatment means of pregnant women with uterine adenomyoma.Retrospective, consecutive, controlled study.University hospital for obstetrics and gynecology.Eighteen pregnant women with uterine adenomyoma.Data collection and statistical analysis.Eighteen pregnant women with uterine adenomyoma were diagnosed by excision of adenomyoma tissue during cesarean section and histopathology. The 18 subjects were retrospectively divided into treatment group (achieving this pregnancy by treatment; 10 cases) and control group (having no difficulty conceiving; 8 cases). The clinicopathologic characteristics and treatment means of the patients were analyzed retrospectively.The mean volume of uterine adenomyoma in the treatment group was larger than that of the control group. The methods of treating women with uterine adenomyoma-associated infertility include GnRH agonist (GnRH-a: 6 cases), GnRH-a and IVF and embryo transfer (3 cases), and traditional Chinese medicines (1 case).Severe uterine adenomyoma correlate with infertility in women of childbearing age. GnRH-a is effective in treating women with uterine adenomyoma-associated infertility.
The risk in the patients with adenomyosis after supracervical hysterectomy

Xinmei Zhang,Yifu Shi

DOI: https://doi.org/10.3969/j.issn.1004-7379.2001.02.014

2001-01-01

Abstract:Objective：To investigate the risk in the patients with adenomyosis after supracervical hysterectomy so as to guide the selection of operation on adenomyosis.Methods：Pathological examination were taken on the cutting edge of uterine specimens in the patients with adenomyosis after supracervical hysterectomy.Results：The incidence of ectopic endometrium appearing in the cuttingedge of uterine specimens was 12%.There was no statistically difference betweenpositive group and negative group about clinical symptoms, complicated endometriosis and the thickness of myometrium (P＞0.05).Yet, there was significantly difference between positive group and negative group about the longitudinal length of uterus (P＜0.05).Conclusions：The longer course of disease,diffuse foci,severe dysmenorrhea,complicated endometriosis may be the high risk factors for the positive incised edge of uterinespecimens, and the longer stump is directly relative to the positive incised edge of uterine specimens.It is advisable to perform total hysterectomy for the aged patients with adenomyosis companied by the high risk factors and to make conventionally pathological examination on the incised edge of uterine specimens in the patients with adenomyosis after supracervical hysterectomy.
Current facts constituting an understanding of the nature of adenomyosis

Veronika Aleksandrovych,Paweł Basta,Krzysztof Gil

DOI: https://doi.org/10.17219/acem/79176

Abstract:Adenomyosis seems to be the most widespread coexistent pathology included under the umbrella of common benign disorders of the human uterus. The incidence of adenomyosis is under discussion since different imaging criteria are used. In the majority of cases, prevalence is determined among women with uterine fibroids and endometriosis or severe gynecological symptoms. This common benign pathology is asymptomatic in 1/3 of cases. Up to 50% of women with infertility are affected by adenomyosis. It seems to be an important risk factor for spontaneous pre-term delivery and pre-term premature rupture of the membranes. Nowadays, the etiology of adenomyosis is still unclear and requires deeper investigation. This review summarizes the aspects of prevalence, co-existence, risk factors, classification, mechanisms of pathogenesis, genes and immunological features, main histological features, animal models, and clinical manifestation of adenomyosis. It might facilitate understanding of the independent nature of such a dual enigma as adenomyosis.
Analysis of 34 Cases of Polypoid Adenomyoma of the Uterus

Wang Xiaoye,Guo Hongyan,Wu Shuying

DOI: https://doi.org/10.3969/j.issn.1009-6604.2010.03.009

2010-01-01

Abstract:Objective To investigate the clinical manifestations and treatment of polypoid adenomyoma of the uterus.Methods Between January 2006 and January 2010,hysteroscopic surgeries were performed on 34 patients with polypoid adenomyoma of the uterus in our department.Postoperative pathological examination showed typical polypoid adenomyoma in 33 cases and atypical polypoid adenomyoma in 1.Results All of the cases underwent hysteroscopic resection of endometrial polyp.No surgical complications occurred.The mean operation time was(28±5)min(ranged from 15 to 60 min),and the intraoperative blood loss ranged from 5 to 10 ml.The size of the resected lesion was 0.5 to 5.0 cm in diameter [mean,(1.5±0.9)cm].The lesions were found located at the uterine fundus and horn in 14 cases(41.2%),at the uterine body in 11(32.4%),lower segment of the uterus in 3(8.8%),and the uterine cervix in 6(17.6%).Among the cases,follow-up was achieved in 33 cases for 1 to 50 months(≥12 months in 28 cases).One of the patients had recurrence and received a second operation 8 months after the first one.Conclusions Pathology,but not B-ultrasonography or hysteroscopy,is the gold standard for the diagnosis of polypoid adenomyoma of the uterus.
Application of multivariable statistical techniques in plant-wide WWTP control strategies analysis.

X. Flores,J. Comas,I. R. Roda,Laureano Jiménez,K. Gernaey

DOI: https://doi.org/10.2166/WST.2007.586

2007-09-01

Abstract:The main objective of this paper is to present the application of selected multivariable statistical techniques in plant-wide wastewater treatment plant (WWTP) control strategies analysis. In this study, cluster analysis (CA), principal component analysis/factor analysis (PCA/FA) and discriminant analysis (DA) are applied to the evaluation matrix data set obtained by simulation of several control strategies applied to the plant-wide IWA Benchmark Simulation Model No 2 (BSM2). These techniques allow i) to determine natural groups or clusters of control strategies with a similar behaviour, ii) to find and interpret hidden, complex and casual relation features in the data set and iii) to identify important discriminant variables within the groups found by the cluster analysis. This study illustrates the usefulness of multivariable statistical techniques for both analysis and interpretation of the complex multicriteria data sets and allows an improved use of information for effective evaluation of control strategies.
Immunohistochemical results and case report of an incidental finding of uterine polypoid adenomyoma after long-time therapy for metrorrhagia

Wiktor Szewczuk,Oksana Szewczuk,Krzysztof Czajkowski,Bartłomiej Grala,Andrzej Semczuk

DOI: https://doi.org/10.1016/j.prp.2020.152998

Abstract:We present a 25-year-old female woman with a 9-year history of metrorrhagia, in whom a uterine polypoid adenomyoma (UPA) was incidentally detected. Intense nuclear staining in the uterine adenomyoma tissue showed an immunoreaction with BAF250a/ARID1A, Arginase-2 as well as 1LRH-2E1/NR5A2, suggesting a role of these proteins and transcriptional activity of their genes in uterine polypoid adenomyoma development. Neither Nidogen-2 nor SF-1/NR5A1 were expressed in UPA.
O1051 Hysteroscopy Used in Atypical Polypoid Adenomyoma Treatment: A Clinical Study of 10 Cases

Y. Zhang,H. Duan,Y. Guo

DOI: https://doi.org/10.1016/s0020-7292(09)61424-7

2009-01-01

Abstract:International Journal of Gynecology & ObstetricsVolume 107, Issue S2 p. S392-S392 Free communication (oral) presentations O1051 Hysteroscopy used in atypical polypoid adenomyoma treatment: A clinical study of 10 cases Y. Zhang, Y. ZhangSearch for more papers by this authorH. Duan, H. DuanSearch for more papers by this authorY. Guo, Y. GuoSearch for more papers by this author Y. Zhang, Y. ZhangSearch for more papers by this authorH. Duan, H. DuanSearch for more papers by this authorY. Guo, Y. GuoSearch for more papers by this author First published: 20 November 2009 https://doi.org/10.1016/S0020-7292(09)61424-7AboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onFacebookTwitterLinked InRedditWechat No abstract is available for this article. Volume107, IssueS2Abstracts of XIX FIGO World Congress of Gynecology and ObstetricsOctober 2009Pages S392-S392 RelatedInformation
Risk factors for adenomyosis in patients with symptomatic uterine leiomyomas.

K. Romanek,M. Bogusiewicz,Aleksandra Bartuzi,T. Rechberger

2010-09-01

Ginekologia Polska

Abstract:OBJECTIVE The aim of the study was to evaluate the potential risk factors for adenomyosis in patients with symptomatic uterine leiomyomas. MATERIAL AND METHODS The medical charts and histopathology reports of 1499 women who underwent hysterectomy between 2003-2007 were retrospectively reviewed. The study group was composed of 135 patients with coexisting uterine leiomyoma and adenomyosis. The control group comprised 176 patients with uterine leiomyoma without adenomyosis. RESULTS Among 233 patients with adenomyosis 135 (57.9%) had associated uterine fibroids. Women who delivered twice or more were at increased risk for adenomyosis in relation to nulliparuos women: RR (95% CI) 2.44 (1.04-5.72), p = 0.040. No relationship was found between adenomyosis and cesarean section rate, abortions, menorrhagia or dysmenorrhea. CONCLUSION Results of our study indicate that multiparity is a risk factor for adenomyosis in women with symptomatic leiomyomas.

Medicine
Adenomyosis and endometriosis: common features

R. I. GABIDULLINA,F. F. MINNULLINA,T. N. SHIGABUTDINOVA,D. I. AKHMETOVA,A. SH. ZARIPOVA,S. I. KHARITONOVA,,,,,,

DOI: https://doi.org/10.32000/2072-1757-2023-4-37-40

2023-01-01

Practical medicine

Abstract:The purpose — to summarize the results of molecular genetic studies of adenomyosis and endometriosis. Material and methods. Review of publications based on search results in the electronic resources PubMed, Elibrary, EMBASE and Google Scholar. Results. Marked differences between endometriosis and adenomyosis in pathogenesis, lesion localisation and clinical features have led to the recognition of adenomyosis as a separate clinical entity. In the new International Classification of Diseases 11th Revision, adenomyosis was removed from the section «Endometriosis» (GA10) and presented as a separate disease «Adenomyosis». Identical KRAS mutations in epithelial cells in endometriosis, adenomyosis and combined endometriosis suggest that adenomyosis and endometriosis are oligoclonal lesions arising from populations of cells of the basal layer of the endometrium carrying a specific driver mutation. Medication strategies that block ovarian steroidogenesis, as well as local estrogen synthesis, are a long-term treatment option for these chronic diseases. Conclusion. The results of molecular genetic studies indicate that endometriosis and adenomyosis are related conditions with a common molecular etiology.
Symptoms and classification of uterine adenomyosis, including the place of hysteroscopy in diagnosis

Stephan Gordts,Grigoris Grimbizis,Rudi Campo

DOI: https://doi.org/10.1016/j.fertnstert.2018.01.006

Abstract:Where histology used the presence of glands and/or stroma in the myometrium as pathognomonic for adenomyosis, imaging uses the appearance of the myometrium, the presence of striations, related to the presence of endometrial tissue within the myometrium, the presence of intramyometrial cystic structures and the size and asymmetry of the uterus to identify adenomyosis. Preliminary reports show a good correlation between the features detected by imaging and the histological findings. Symptoms associated with adenomyosis are abnormal uterine bleeding, pelvic pain (dysmenorrhea, chronic pelvic pain, dyspareunia), and impaired reproduction. However a high incidence of existing comorbidity like fibroids and endometriosis makes it difficult to attribute a specific pathognomonic symptom to adenomyosis. Heterogeneity in the reported pregnancy rates after assisted reproduction is due to the use of different ovarian stimulation protocols and absence of a correct description of the adenomyotic pathology. Current efforts to classify the disease contributed a lot in elucidated the potential characteristics that a classification system should be relied on. The need for a comprehensive, user friendly, and clear categorization of adenomyosis including the pattern, location, histological variants, and the myometrial zone seems to be an urgent need. With the uterus as a possible unifying link between adenomyosis and endometriosis, exploration of the uterus should not only be restricted to the hysteroscopic exploration of the uterine cavity but in a fusion with ultrasound.
Pathogenesis of Adenomyosis: an Update on Molecular Mechanisms.

Silvia Vannuccini,Claudia Tosti,Francisco Carmona,S. Joseph Huang,Charles Chapron,Sun-Wei Guo,Felice Petraglia

DOI: https://doi.org/10.1016/j.rbmo.2017.06.016

IF: 4.567

2017-01-01

Reproductive BioMedicine Online

Abstract:Adenomyosis is a uterine disorder becoming more commonly diagnosed in women of reproductive age because of diagnostic imaging advancements. The new epidemiological scenario and the clinical evidence of pelvic pain, abnormal uterine bleeding and infertility are changing the classic perspective of adenomyosis as a premenopausal disease. In the last decade, the evaluation of multiple molecular mediators has improved our knowledge of pathogenic mechanisms of adenomyosis, supporting that this is an independent disease from endometriosis. Although they share common genetic mutations and epigenetic changes in sex steroid hormone receptors and similar inflammatory mediators, an increasing number of recent studies have shown pathogenic pathways specific for adenomyosis. A PubMed search up to October 2016 summarizes the key mediators of pain, abnormal uterine bleeding and infertility in adenomyosis, including sex steroid hormone receptors, inflammatory molecules, extracellular matrix enzymes, growth factors and neuroangiogenic factors.
Adenomyosis: Mechanisms and Pathogenesis

Junyu Zhai,Silvia Vannuccini,Felice Petraglia,Linda C Giudice,Linda C. Giudice

DOI: https://doi.org/10.1055/s-0040-1716687

2020-05-01

Seminars in Reproductive Medicine

Abstract:Abstract Adenomyosis is a common disorder of the uterus, and is associated with an enlarged uterus, heavy menstrual bleeding (HMB), pelvic pain, and infertility. It is characterized by endometrial epithelial cells and stromal fibroblasts abnormally found in the myometrium where they elicit hyperplasia and hypertrophy of surrounding smooth muscle cells. While both the mechanistic processes and the pathogenesis of adenomyosis are uncertain, several theories have been put forward addressing how this disease develops. These include intrinsic or induced (1) microtrauma of the endometrial–myometrial interface; (2) enhanced invasion of endometrium into myometrium; (3) metaplasia of stem cells in myometrium; (4) infiltration of endometrial cells in retrograde menstrual effluent into the uterine wall from the serosal side; (5) induction of adenomyotic lesions by aberrant local steroid and pituitary hormones; and (6) abnormal uterine development in response to genetic and epigenetic modifications. Dysmenorrhea, HMB, and infertility are likely results of inflammation, neurogenesis, angiogenesis, and contractile abnormalities in the endometrial and myometrial components. Elucidating mechanisms underlying the pathogenesis of adenomyosis raise possibilities to develop targeted therapies to ameliorate symptoms beyond the current agents that are largely ineffective. Herein, we address these possible etiologies and data that support underlying mechanisms.

obstetrics & gynecology,reproductive biology
Impact of adenomyosis on the prognosis of patients with endometrial cancer

Diego Raimondo,Antonio Raffone,Antonio Travaglino,Manuela Maletta,Paolo Casadio,Marco Ambrosio,Anna Chiara Aru,Angela Santoro,Gian Franco Zannoni,Luigi Insabato,Antonio Mollo,Fulvio Zullo,Renato Seracchioli

DOI: https://doi.org/10.1002/ijgo.13818

2021-07-18

Abstract:BackgroundDespite the high prevalence of adenomyosis in hysterectomy specimens of endometrial carcinoma (EC) patients, the relationship between adenomyosis and EC prognosis appears unclear. ObjectiveTo assess the prognostic value of coexistent adenomyosis in patients with EC. MethodsA systematic review and meta-analysis was performed by searching six electronic databases for studies reporting data on prognosis of EC patients with and without coexistent adenomyosis. Studies with patient selection based on prognostic factors were excluded. Pooled univariate hazard ratio (HR) analyses for overall survival (OS) and disease-free survival (DRF) were performed, using EC patients without adenomyosis as a control group. For DFS, pooled multivariate HR analysis was also evaluable. ResultsThree studies of 2505 EC patients (553 with and 1952 without adenomyosis) were included. Compared with EC patients without adenomyosis, EC patients with coexistent adenomyosis showed a pooled HR of 0.533 (CI 95%, 0.329–0.864) for OS at univariate analysis; 0.536 (CI 95%, 0.334–0.859) for DFS at univariate analysis; and 0.875 (CI 95%, 0.331–2.315) for DFS at multivariate analysis. ConclusionIn EC patients with coexistent adenomyosis, the risk of death is halved compared with EC patients without adenomyosis. However, the independence of this association needs to be verified in future studies.

obstetrics & gynecology
Atypical polypoid adenomyoma of the uterus: a clinicopathologic study of 10 cases

Dongmei BAO,Danhua SHEN

DOI: https://doi.org/10.3969/j.issn.1672-1861.2008.04.004

2008-01-01

Abstract:Objective To explore the clinicopathological features of the atypical polypoid adenomyoma (APA) of the uterus.Methods Clinical data and HE slides were reviewed and immunohistochemical stains were performed in 10 cases of APA,with follow-up in 9 cases.Results Patients were 31 to 52 years old (mean at 41.1). All but two of the patients were premenopausal,and 4 with infertility. Except that one was unclear of its location,four arose at low segment of uterus,one in cervical canal,and four at the uterine fundus. Histologically,the lesions featured a polypoid proliferation of irregular,atypical endometrial glands,with a smooth-muscle and fibroblastic stroma. Squamous metaplasia was found in seven cases. Seven patients underwent polypectomy or curettage and three hysterectomy. Nine patients were followed up for 3 to 92 months after diagnosis (mean for 41.3 months). One patient with initial polypectomy recurred at 15 months and was free of disease for another 17 months after secondary polypectomy. All the other patients did not show any sign of recurrence.Conclusions Atypical polypoid adenomyofibromas have histological features of proliferation of architecturally complex and cytological atypical glands within a myofibromatous stroma,which should make differential diagnosis from endometrioid carcinoma. Most APA is typically indolent,with a few present low malignant potential of recurrence.
Significance of adenomyosis on tumor progression and survival outcome of endometrial cancer

Koji Matsuo,Sigita S Cahoon,Marc Gualtieri,Christopher A Scannell,Carrie E Jung,Tadao Takano,Richard J Paulson,Laila I Muderspach,Lynda D Roman

DOI: https://doi.org/10.1245/s10434-014-3880-6

Abstract:Background: To examine the effects of adenomyosis on tumor progression and survival outcome of endometrial cancer patients. Methods: This is a retrospective study examining stage I-IV endometrial cancer patients who underwent hysterectomy-based surgical staging (n = 571), and endometrial hyperplasia patients who underwent hysterectomy (n = 213). Clinical demographics, histopathological factors, and survival outcomes were analyzed based on the presence or absence of adenomyosis. Results: Among the endometrial cancer cohort, adenomyosis was observed in 47.5 % of cases and was significantly associated with lower grade (grade 1-2 tumors, 81.2 vs. 73.3 %; p = 0.028), earlier stage (stage I disease, 74.8 vs. 64.3 %; p = 0.023), and lower likelihood of deep myometrial invasion (19.2 vs. 28.2 %; p = 0.039) and cervical invasion (13.7 vs. 21.2 %; p = 0.024) than those without adenomyosis. In survival analysis, endometrial cancer coexisting with adenomyosis was associated with a significantly better disease-free survival (5-year rate, 89.2 vs. 78.2 %; p < 0.001) and overall survival (91.8 vs. 83.9 %; p = 0.004) after hysterectomy. In multivariate analysis, controlling for other significant variables in univariate analysis, presence of adenomyosis remained an independent prognostic factor associated with decreased risk of disease recurrence after surgery (hazard ratio [HR] 0.53; 95 % confidence interval [CI] 0.30-0.92; p = 0.023). Endometrial hyperplasia had a significantly increased incidence of adenomyosis when compared with type I endometrial cancer (grade 1-2 endometrioid adenocarcinoma, n = 411) on multivariate analysis (62.9 vs. 48.9 %; HR 1.88; 95 % CI 1.32-2.69; p < 0.001). Conclusions: Adenomyosis appears to be associated with less aggressive tumor behavior of endometrial cancer, suggesting that it may have inhibitory effects on the progression of this disease.
Clinical Characteristics of Patients with Endometrial Cancer and Adenomyosis

Paolo Casadio,Antonio Raffone,Manuela Maletta,Antonio Travaglino,Diego Raimondo,Ivano Raimondo,Angela Santoro,Roberto Paradisi,Gian Franco Zannoni,Antonio Mollo,Renato Seracchioli

DOI: https://doi.org/10.3390/cancers13194918

2021-09-30

Cancers

Abstract:A better endometrial cancer (EC) prognosis in patients with coexistent adenomyosis has been reported. Unfortunately, it is still unclear if this better prognosis is related to a more favorable clinical profile of adenomyosis patients. We aimed to evaluate differences in the clinical profiles of EC patients with and without adenomyosis. A systematic review and meta-analysis was performed by searching seven electronics databases for all studies that allowed extraction of data about clinical characteristics in EC patients with and without adenomyosis. Clinical characteristics assessed were: age, Body Mass Index (BMI), premenopausal status, and nulliparity. Mean difference in mean ± standard deviation (SD) or odds ratio (OR) for clinical characteristics between EC patients with and without adenomyosis were calculated for each included study and as a pooled estimate, and graphically reported on forest plots with a 95% confidence interval (CI). The Z test was used for assessing the overall effect by considering a p value < 0.05 as significant. Overall, eight studies with 5681 patients were included in the qualitative analysis, and seven studies with 4366 patients in the quantitative analysis. Pooled mean difference in mean ± SD between EC women with and without adenomyosis was −1.19 (95% CI: −3.18 to 0.80; p = 0.24) for age, and 0.23 (95% CI: −0.62 to 1.07; p = 0.60) for BMI. When compared to EC women without adenomyosis, EC women with adenomyosis showed a pooled OR of 1.53 (95% CI: 0.92 to 2.54; p = 0.10) for premenopausal status, and of 0.60 (95% CI: 0.41 to 0.87; p = 0.007) for nulliparity. In conclusion, there are not significant differences in clinical characteristics between EC patients with and without adenomyosis, with the exception for nulliparity. Clinical features seem to not underlie the better EC prognosis of patients with adenomyosis compared to patients without adenomyosis.

oncology
Current Medical Therapy for Adenomyosis: From Bench to Bedside

Andrea Etrusco,Fabio Barra,Vito Chiantera,Simone Ferrero,Stefano Bogliolo,Giulio Evangelisti,Engin Oral,Mariana Pastore,Alberto Izzotti,Renato Venezia,Marcello Ceccaroni,Antonio Simone Laganà

DOI: https://doi.org/10.1007/s40265-023-01957-7

Drugs

Abstract:Adenomyosis, characterized by the growth of endometrial tissue within the uterine wall, poses significant challenges in treatment. The literature primarily focuses on managing abnormal uterine bleeding (AUB) and dysmenorrhea, the main symptoms of adenomyosis. Nonsteroidal anti-inflammatory drugs (NSAIDs) and tranexamic acid provide limited support for mild symptoms or symptom re-exacerbation during hormone therapy. The levonorgestrel-releasing intrauterine system (LNG-IUS) is commonly employed in adenomyosis management, showing promise in symptom improvement and reducing uterine size, despite the lack of standardized guidelines. Dienogest (DNG) also exhibits potential benefits, but limited evidence hinders treatment recommendations. Danazol, while effective, is limited by androgenic side effects. Combined oral contraceptives (COCs) may be less effective than progestins but can be considered for contraception in young patients. Gonadotropin-releasing hormone (GnRH) agonists effectively manage symptoms but induce menopausal symptoms with prolonged use. GnRH antagonists are a recent option requiring further investigation. Aromatase inhibitors (AIs) show promise in alleviating AUB and pelvic pain, but their safety necessitates exploration and limited use within trials for refractory patients. This review highlights the complexity of diagnosing adenomyosis, its coexistence with endometriosis and uterine leiomyomas, and its impact on fertility and quality of life, complicating treatment decisions. It emphasizes the need for research on guidelines for medical management, fertility outcomes, long-term effects of therapies, and exploration of new investigational targets. Future research should optimize therapeutic strategies, expand our understanding of adenomyosis and its management, and establish evidence-based guidelines to improve patient outcomes and quality of life.
Expression of Endometrial Receptivity Markers throughout the Menstrual Cycle in Women with and without Uterine Adenomyosis

Christina Anna Stratopoulou,Ines El Grari,Alessandra Camboni,Jacques Donnez,Marie-Madeleine Dolmans

DOI: https://doi.org/10.3390/jcm13175016

IF: 3.9

2024-08-26

Journal of Clinical Medicine

Abstract:Background/Objectives: While it is known that adenomyosis is associated with poor reproductive outcomes, the underlying mechanisms are unclear, and to date, there is no standard treatment protocol for these patients. Endometrium from adenomyosis patients is characterized by several abnormalities, potentially resulting in impaired receptivity and subsequent implantation failure. Methods: Endometrial biopsies were collected from 26 women with adenomyosis and 26 control subjects. Immunohistochemistry was performed to evaluate the expression of markers of endometrial receptivity, namely the progesterone receptor (PR), glycodelin, leukemia inhibitory factor (LIF), homeobox A10 (HOXA10), integrin beta chain beta 3 (integrin β3) and osteopontin. Scanning electron microscopy was used to observe pinopodes on the surface of mid-secretory endometrial epithelium. Results: PR, LIF and osteopontin expression were all found to be weaker in secretory-phase stroma from adenomyosis patients than in healthy controls. HOXA10 expression was decreased in adenomyosis during the secretory phase, and also the proliferative phase, where it reached statistical significance in both epithelial and stromal compartments. Glycodelin and integrin β3 levels did not differ between diseased and healthy tissues in any of the cycle phases. Pinopodes were fewer and at later developmental stages in adenomyosis compared to those on the surface of healthy endometrium from the same time period of the menstrual cycle. Conclusions: Endometrium from adenomyosis patients is characterized by abnormal expression of various receptivity markers. The stromal compartment appears to be affected most, showing reduced expression of PR, LIF and osteopontin in the secretory phase and lower levels of HOXA10 during both proliferative and secretory phases. Decreased receptivity due to impaired stromal decidualization may contribute to poor reproductive outcomes in adenomyosis patients.

medicine, general & internal
Adenomyosis Localized in Both the Anterior and Posterior Myometrium Is Associated with Deep Rectal Endometriosis: A Retrospective Study

Konstantin Schawlochow,Nicolas Samartzis,Laurin Burla,Markus Eberhard,Dimitrios Rafail Kalaitzopoulos,Brigitte Leeners

DOI: https://doi.org/10.3390/biomedicines12112527

IF: 4.757

2024-11-05

Biomedicines

Abstract:Background: Endometriosis and adenomyosis are two closely related, estrogen-dependent, benign gynecological diseases. The available evidence on their common pathogenesis and association is limited and often does not address the heterogeneity of both entities. The aim of our study is to investigate the association between different types and localizations of adenomyosis and endometriosis phenotypes, using magnetic resonance imaging (MRI) and laparoscopic findings. Methods: We performed a retrospective observational study involving premenopausal women over 18 years old who underwent laparoscopic surgery for endometriosis and were pre-operatively diagnosed with adenomyosis through MRI examination at the Cantonal Hospital of Schaffhausen, Switzerland between 2011 and 2022. Results: Of 130 patients with adenomyosis, 23 (17.7%) women had adenomyosis only in the anterior wall (group 1), 38 (29.2%) only in the posterior wall (group 2), and 69 (53.1%) in both the anterior and posterior wall (group 3). Women in group 1 experienced significantly more dysuria compared to the two other groups (p = 0.018), while the prevalence of other pain symptoms (dysmenorrhea, dyspareunia, dyschesia) was comparable between the groups. Women in group 3 had significantly thicker anterior and posterior myometrium compared to groups 1 and 2 (p < 0.001). Co-existence of deep rectal endometriosis was more frequent in women from group 3 compared to groups 1 and 2 (p = 0.039) and in women with adenomyosis in the outer (extrinsic) compared to adenomyosis in the inner myometrium (intrinsic) (p < 0.001). Conclusions: This study provides evidence of an association between the localization of adenomyosis and the distribution of concomitant endometriosis. Specifically, adenomyosis localized in both the anterior and posterior wall appears to be more proliferative compared to adenomyosis found only in the anterior or posterior wall. This is indicated by its association with higher uterine volume, thicker posterior junctional zone, and greater myometrial thickness and with a higher co-existence with deep rectal endometriosis. These findings support an association between the development of specific subtypes of both entities, which represents a valuable resource for the identification of future targets for the treatment and clinical management of adenomyosis and endometriosis.

biochemistry & molecular biology,medicine, research & experimental,pharmacology & pharmacy

Relationship between adenomyosis and uterine polyps.

A Multiple Perspectives on Atypical Polypoid Adenomyoma of Uterus.

Clinicopathologic characteristics of uterine adenomyoma in pregnant women.

The risk in the patients with adenomyosis after supracervical hysterectomy

Current facts constituting an understanding of the nature of adenomyosis

Analysis of 34 Cases of Polypoid Adenomyoma of the Uterus

Application of multivariable statistical techniques in plant-wide WWTP control strategies analysis.

Immunohistochemical results and case report of an incidental finding of uterine polypoid adenomyoma after long-time therapy for metrorrhagia

O1051 Hysteroscopy Used in Atypical Polypoid Adenomyoma Treatment: A Clinical Study of 10 Cases

Risk factors for adenomyosis in patients with symptomatic uterine leiomyomas.

Adenomyosis and endometriosis: common features

Symptoms and classification of uterine adenomyosis, including the place of hysteroscopy in diagnosis

Pathogenesis of Adenomyosis: an Update on Molecular Mechanisms.

Adenomyosis: Mechanisms and Pathogenesis

Impact of adenomyosis on the prognosis of patients with endometrial cancer

Atypical polypoid adenomyoma of the uterus: a clinicopathologic study of 10 cases

Significance of adenomyosis on tumor progression and survival outcome of endometrial cancer

Clinical Characteristics of Patients with Endometrial Cancer and Adenomyosis

Current Medical Therapy for Adenomyosis: From Bench to Bedside

Expression of Endometrial Receptivity Markers throughout the Menstrual Cycle in Women with and without Uterine Adenomyosis

Adenomyosis Localized in Both the Anterior and Posterior Myometrium Is Associated with Deep Rectal Endometriosis: A Retrospective Study